Shimizu N, Ogawa A, Hayashi A, Shichiri M, et al. Discordance in the reduction rate between glycated albumin and glycated hemoglobin levels in type 2 diabetes patients receiving SGLT2 inhibitors. J Diabetes Complications 2022 Jun 2:108225. doi: 10.1016/j.jdiacomp.2022.108225.
PMID: 35690574